Recurrent Childhood Visual Pathway and Hypothalamic Glioma: Clinical Trials

4 trials for Recurrent Childhood Visual Pathway and Hypothalamic Glioma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed. 4 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 24Completed 4

Follow Recurrent Childhood Visual Pathway and Hypothalamic Glioma: new trials by email Literature Review of Recurrent Childhood Visual Pathway and Hypothalamic Glioma trials Research Report on Recurrent Childhood Visual Pathway and Hypothalamic Glioma

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Cilengitide in Treating Younger Patients With Recurrent or Progressive High-Grade Glioma That Has Not Responded to Standard Therapy
cilengitide, laboratory biomarker analysis, pharmacological study - Childhood High-grade Cerebellar Astrocytoma, Childhood High-grade Cerebral Astrocytoma
Phase 2CompletedNational Cancer Institute (NCI)302008-06-012018-08-01
Oxaliplatin in Treating Young Patients With Recurrent Solid Tumors That Have Not Responded to Previous Treatment
oxaliplatin - Childhood Central Nervous System Germ Cell Tumor, Childhood Extragonadal Germ Cell Tumor
Phase 2CompletedNational Cancer Institute (NCI)1802004-10-012013-06-05
Tipifarnib in Treating Young Patients With Recurrent or Progressive High-Grade Glioma, Medulloblastoma, Primitive Neuroectodermal Tumor, or Brain Stem Glioma
tipifarnib - Childhood High-grade Cerebral Astrocytoma, Childhood Oligodendroglioma
Phase 2CompletedNational Cancer Institute (NCI)902003-11-012013-10-08
Irinotecan in Treating Children With Refractory Solid Tumors
irinotecan hydrochloride - Childhood Central Nervous System Germ Cell Tumor, Childhood Choroid Plexus Tumor
Phase 2CompletedChildren's Oncology Group1811999-10-012013-06-14

Narrower conditions

Astrocytoma (4)  ·  Optic Nerve Glioma (4)  ·  Oligodendroglioma (3)  ·  Familial ependymoma (2)  ·  Medulloblastoma (2)  ·  Neuroblastoma (2)  ·  Neuroectodermal Tumors, Primitive, Peripheral (2)  ·  Osteosarcoma (2)  ·  Adrenocortical Carcinoma (1)  ·  Carcinoma, Renal Cell (1)  ·  Choroid Plexus Neoplasms (1)  ·  Colonic Neoplasms (1)  ·  Hepatoblastoma (1)  ·  Nasopharyngeal Neoplasms (1)  ·  Ovarian Germ Cell Cancer (1)

Broader conditions

Cranial Nerve Diseases (4)  ·  Cranial Nerve Neoplasms (4)  ·  Eye Diseases (4)  ·  Glioma (4)  ·  Neoplasms (4)  ·  Neoplasms by Histologic Type (4)  ·  Neoplasms by Site (4)  ·  Neoplasms, Germ Cell and Embryonal (4)  ·  Neoplasms, Glandular and Epithelial (4)  ·  Neoplasms, Nerve Tissue (4)  ·  Neoplasms, Neuroepithelial (4)  ·  Nervous System Diseases (4)  ·  Nervous System Neoplasms (4)  ·  Neuroectodermal Tumors (4)  ·  Optic Nerve Diseases (4)

Interventions

Cilengitide (1)  ·  Irinotecan (1)  ·  Oxaliplatin (1)  ·  tipifarnib (1)

Sponsors

National Cancer Institute (NCI) (3)  ·  Children's Oncology Group (1)

Countries

United States (4)  ·  Canada (1)

Top investigators

Lisa Bomgaars (1)  ·  Maryam Fouladi (1)  ·  Orren Beaty (1)  ·  Tobey MacDonald (1)

NIH funding

U10CA098543 (4)